Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mayne Pharma Group Ltd

MYX
Current price
4.88 AUD -0.08 AUD (-1.61%)
Last closed 4.89 AUD
ISIN AU000000MYX0
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Australian Securities Exchange
Capitalization 449 116 519 AUD
Yield for 12 month +12.70 %
1Y
3Y
5Y
10Y
15Y
MYX
21.11.2021 - 28.11.2021

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women's Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia. Address: 1538 Main North Road, Salisbury South, SA, Australia, 5106

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.41 AUD

P/E ratio

Dividend Yield

Current Year

+394 056 053 AUD

Last Year

+186 378 947 AUD

Current Quarter

+203 522 853 AUD

Last Quarter

+190 784 973 AUD

Current Year

+221 851 514 AUD

Last Year

+27 246 294 AUD

Current Quarter

+114 710 980 AUD

Last Quarter

+75 450 651 AUD

Key Figures MYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 19 082 965 AUD
Operating Margin TTM -3.29 %
PE Ratio
Return On Assets TTM -2.33 %
PEG Ratio
Return On Equity TTM -30.98 %
Wall Street Target Price 9.41 AUD
Revenue TTM 394 307 834 AUD
Book Value 5.68 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 52.6 %
Dividend Yield
Gross Profit TTM 84 757 112 AUD
Earnings per share -2.15 AUD
Diluted Eps TTM -2.15 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -44.86 %

Dividend Analytics MYX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

2 %

Dividend History MYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 18.01.2023
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.01.2023
Dividend Date

Stock Valuation MYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 285.7143
Enterprise Value Revenue 0.8332
Price Sales TTM 1.1171
Enterprise Value EBITDA -1.0926
Price Book MRQ 0.9553

Financials MYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MYX

For 52 weeks

3.8 AUD 7.57 AUD
50 Day MA 4.68 AUD
Shares Short Prior Month
200 Day MA 5.41 AUD
Short Ratio
Shares Short
Short Percent